A public biotech should be honest and upfront about the actual data and how their drugs have a market advantage.
Pphm has failed to deliver on their PR promises for updating the data. It's been 18 months since the Hcv PR for example. All I do is keep asking for the information they are not giving out. Should not be hard to do if they have the goods.
If it helps you though, you can always wook it up.
You're absolutely right Evora; Peregrine should be more transparent and forthcoming with their research findings. Investors have a right to know, being that it is THEIR $ supporting the company.
Management seems a bit pretentious to me, and I wish they would take note of how many shareholders are getting tired of this.